SRT3025 HCl is primarily researched for its potential therapeutic applications, particularly in the field of aging and age-related diseases. It is known to activate sirtuins, a class of proteins that play a crucial role in regulating cellular health, metabolism, and longevity. This compound has shown promise in preclinical studies for enhancing mitochondrial function, reducing inflammation, and improving metabolic health. It is being explored as a potential treatment for conditions such as diabetes, cardiovascular diseases, and neurodegenerative disorders. Additionally, SRT3025 HCl is investigated for its ability to protect against oxidative stress and DNA damage, which are key factors in the aging process. Its applications extend to the development of interventions aimed at extending healthy lifespan and mitigating the effects of chronic diseases associated with aging.